Peripheral Neuropathy Trial, Recruiting NCT06102304 Sponsor: Cairo University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06102304
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a one-sided nerve problem in the lower part of the neck (at the C5-C6 and/or C6-C7 levels), confirmed by an MRI scan
  • People who have pain and tenderness in active trigger points (tight, sensitive muscle knots) in the upper trapezius muscle, which runs along the top of the shoulder and neck
  • People aged between 36 and 46 years old
  • People whose symptoms have been present for more than 3 months
  • People whose nerve signal test results (a specific electrical test called DSSEPs) show a difference of 50% or more between the two sides of the body (confirm with trial site)

Who may not be able to join:

  • People who have bony growths pressing on nerves at the back of the spine (posterior osteophytes)
  • People who have narrowing of the spinal canal (spinal canal stenosis)
  • People who have rheumatoid arthritis
  • People who have problems with their vestibular system, which affects balance (vestibular insufficiency)
  • People who have osteoporosis (weakened, brittle bones)
  • People who show any signs or symptoms of spinal cord damage or pressure (myelopathy)
  • People who have any problems with their ability to feel deep sensations (such as vibration or position sense)
  • People who have other conditions in the upper neck or arm area that could cause similar symptoms, such as referred pain from certain spinal joints, rotator cuff tendonitis, cervical rib syndrome, or a trapped nerve in the arm

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Engy BadrEldin S Moustafa, PhD, Faculty of Physical Therapy, Cairo University, Egypt

Phone: 00201099445112

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 April 2025
Est. completion
29 November 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Amplitude of median nerve dermatomal somatosensory evoked potential; Distal Latency of median nerve dermatomal somatosensory evoked potential; Pain Pressure Threshold on upper trapezius; Hand grip Strength; Level of radiating pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov